Desire · Dryness · Comfort
Desire, arousal, vaginal dryness and sexual comfort deserve attention. Explore care guided by your preferences, life stage and health history.
Enrollment opens later. Consultation required.
Explore your options Know your options
Compare options to discuss with a clinician.
May be considered for vaginal dryness and related discomfort.
When menopause-related dryness or discomfort makes intimacy less comfortable, local vaginal estradiol may help relieve vaginal symptoms. It targets comfort rather than desire and is not a treatment for every sexual concern. Symptoms, health history and the need for an examination guide suitability.
Packaging is illustrative and does not confirm product, formulation or pharmacy availability. A consultation does not guarantee a prescription. Read important safety information
At a glance
| Option | What to discuss | Before choosing |
|---|---|---|
| Vaginal estradiol | May be considered for vaginal dryness and related discomfort. | Individual evaluation; risks, formulation and availability reviewed before treatment. |
Before you decide
Understand eligibility, limits and safety before considering treatment.
Concerns about desire, arousal, orgasm or comfort are valid reasons to seek information. Sexual desire varies; a change does not automatically mean a disorder. You do not need to choose a medication or identify a diagnosis first. The planned evaluation considers what matters to you without assuming that sexual wellness is about meeting a partner’s expectations.
No. Sexual concerns can have several contributing factors, including health conditions, medicines and life circumstances. Menopause may be relevant for some people, but a concern does not automatically mean menopause or a hormone deficiency.
Vaginal dryness, discomfort and changes in desire may overlap with perimenopause or menopause. The two categories are related entry points, not mutually exclusive diagnoses. Overlapping concerns do not automatically require two purchases or two separate treatment plans.
Treatment depends on the concern and clinical findings. Local vaginal estradiol may be considered for appropriate vaginal symptoms; it is not interchangeable with medication evaluated for low sexual desire. Nonmedication approaches or a different type of assessment may also be appropriate.
No. The FDA-approved bremelanotide product is for certain premenopausal women with acquired, generalized low desire that causes distress and is not explained by another condition, medication or relationship problem. It is not for every sexual concern. Compounded PT-141 formulations are not equivalent to that approved product. Mednaro’s exact prescribing and fulfillment pathway has not yet been confirmed.
That depends on the concern. Pain or other symptoms may require an examination or another care setting. Mednaro has not confirmed its consultation format, follow-up schedule or state-specific service availability. This public page does not collect intimate or clinical details.
No guesswork
Pricing is being finalized. No payment is taken in this planner.
More ways to plan for care
Explore planned HSA/FSA payments and buy now, pay later options.
These payment options are not active yet. Acceptance, eligible expenses, financing approval, fees and repayment terms will be confirmed before enrollment. HSA/FSA eligibility depends on your plan and the expense; financing is subject to provider eligibility and terms.
Pricing & availability
Review included services and separate charges before payment.
No. Clinical enrollment is not yet open. You can explore this information and contact general support with administrative questions. Do not send medical history, medications or sensitive personal details by ordinary email.
Pricing will be shown before enrollment opens. What is included, any separate costs, insurance acceptance and cancellation terms will be explained before you choose care.
Services and treatment availability vary by state and clinical eligibility. Availability will be confirmed before enrollment opens.
Mednaro provides the technology experience and nonclinical support. Medical decisions are made by appropriately licensed clinicians through independent clinical groups. When prescribed, medication is dispensed by licensed third-party pharmacies. Fulfillment and follow-up arrangements will be confirmed before enrollment opens.
A consultation does not guarantee a prescription. A clinician may recommend further evaluation or another next step. Any payment and refund terms will be explained before a paid evaluation becomes available.
Keep exploring
